# HeartFlow, Inc.

Organization · id `cardio:org-heartflow-inc` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=HeartFlow%2C+Inc.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: HeartFlow, Inc.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography (`cardio:ct-nct01233518`)
- Sponsors: REWRITE-CAD Protocol: Risk Evaluation With AI-CPA to Reduce Progression and Improve Lifetime Care for Patients With Known Coronary Artery Disease (`cardio:ct-nct07834372`)
- Sponsors: REFINE-CAC Protocol: Risk Evaluation With AI-CPA + HCS For Patients IN Whom Calcium is confirmEd to Improve Coronary Artery Disease Care (`cardio:ct-nct07853716`)

## Provenance

Content hash: 804d8ecbf7ab20ab947761156ec60bdae8caa96ef4c8915c7c61c381ffb686ce
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
